| Hans-Günter Meyer-Thompson | Buprenorphin
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine.
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine.
Stein MD, VanNoppen D, Herman DS, Anderson BJ, Conti M, Bailey GL.
J Subst Abuse Treat. 2021 Nov 14:108661. doi: 10.1016/j.jsat.2021.108661. Epub ahead of print. PMID: 34801283.
Abstract